Compare PepsiCo, Inc. (PEP) vs RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) (RELX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
PepsiCo, Inc. vs RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) — how do they compare? PepsiCo, Inc. trades at $130.98 (market cap $176.16B), while RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) trades at $38.04 (market cap $63.89B). The key difference: PepsiCo, Inc. is far larger — about 2.8× RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)'s market cap, and PepsiCo, Inc. pays the higher dividend (4.58%). Which is the better fit depends on your goals.
| PEP | RELX | |
|---|---|---|
Market Cap | $176.16B | $63.89B |
Volume | 9,536,018 | 2,760,502 |
Sector | Consumer Staples | Industrials |
52-Week High | $170.44 | $46.80 |
52-Week Low | $123.64 | $27.73 |
Typical Hold Time | 108 Days | — |
Enterprise Value | $216.88B | $75.40B |
Dividend Yield | 4.58% | 2.47% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PepsiCo (PEP) trades at $127.28, up 0.44% today, with a bearish technical signal but strong fundamentals including four consecutive quarterly EPS beats. The stock shows a P/E of 16.01 and a net income margin of 11.09%, supported by robust cash flow from operations of $12.09B in 2025. Recent news highlights price adjustments for snacks like Doritos to address consumer pushback on high prices.
The outlook is cautiously optimistic with a consensus price target of $142.38 implying 12% upside, though technical indicators suggest near-term resistance. Risks include competitive pressures and sensitivity to consumer spending trends, but the company's consistent profitability and dividend payments provide stability.
RELX trades at $36.70, up 0.44% with neutral technical signals. The company demonstrates strong profitability with 23.27% net margins and 132.36% ROE, though valuation metrics appear elevated with P/E of 22.21 and P/B of 38.89. Recent earnings show mixed results with Q2 2026 beating expectations while Q4 2025 missed. Analyst sentiment remains positive with 71% buy ratings and consensus price target of $26.00.
The investment case balances strong fundamentals against premium valuation. Growth catalysts include AI-driven product adoption and margin expansion, while risks involve competitive pressures and valuation concerns. With solid cash flow generation and institutional support, RELX offers quality exposure but requires monitoring of valuation multiples and competitive dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About PepsiCo, Inc.
PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.
Read more on PEP →About RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)
RELX PLC is a UK-based information and analytics company operating across four segments: Risk (fraud prevention and compliance analytics via LexisNexis Risk Solutions), Scientific, Technical & Medical (Elsevier's research and clinical content), Legal (LexisNexis Legal & Professional's research tools), and Exhibitions (RX's trade events). It serves professional, business, and government customers worldwide.
Read more on RELX →
